Chevallard Daniel R.

CIK 00017061763 companiesSOLANA BEACH, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001706176

Recent Transactions

50 trades

Award
LENZ Therapeutics, Inc.$LENZ
Restricted Stock Unit
2026-01-02+14,000→ 14,000 total
Award
LENZ Therapeutics, Inc.$LENZ
Stock Option (right to buy)
2026-01-02+84,200→ 84,200 total
Purchase
LENZ Therapeutics, Inc.$LENZ
Common Stock
2025-11-07$22.76/sh+2,178→ 5,386 total
Purchase
LENZ Therapeutics, Inc.$LENZ
Common Stock
2025-11-07$22.71/sh+20→ 3,208 total
Award
LENZ Therapeutics, Inc.$LENZ
Stock Option (right to buy)
2025-01-09+70,444→ 70,444 total
Purchase
LENZ Therapeutics, Inc.$LENZ
Common Stock
2024-05-14$15.68/sh+3,188→ 3,188 total
Award
LENZ Therapeutics, Inc.$LENZ
Stock Option (right to buy)
2024-03-21+200,000→ 200,000 total
Award
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2024-03-12+200,000→ 200,000 total
Sale
Viracta Therapeutics, Inc.$VIRX
Common Stock
2024-02-27$0.73/sh−3,405→ 102,306 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Restricted Stock Units
2024-02-25−6,889→ 34,444 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2024-02-25+6,889→ 105,711 total
Sale
Viracta Therapeutics, Inc.$VIRX
Common Stock
2023-11-28$0.50/sh−3,720→ 98,822 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Restricted Stock Units
2023-11-25−6,889→ 41,333 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2023-11-25+6,889→ 102,542 total
Sale
Viracta Therapeutics, Inc.$VIRX
Common Stock
2023-08-28$1.45/sh−3,512→ 95,653 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Restricted Stock Units
2023-08-25−6,888→ 48,222 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2023-08-25+6,888→ 99,165 total
Sale
Viracta Therapeutics, Inc.$VIRX
Common Stock
2023-05-25$1.42/sh−3,635→ 92,277 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2023-05-25+6,889→ 95,912 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Restricted Stock Units
2023-05-25−6,889→ 55,110 total
Award
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2023-03-16+200,000→ 200,000 total
Sale
Viracta Therapeutics, Inc.$VIRX
Common Stock
2023-02-27$1.68/sh−3,599→ 89,023 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Restricted Stock Units
2023-02-25−6,889→ 61,999 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2023-02-25+6,889→ 92,622 total
Sale
Viracta Therapeutics, Inc.$VIRX
Common Stock
2022-11-28$2.72/sh−3,532→ 85,733 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2022-11-25+6,889→ 89,265 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Restricted Stock Units
2022-11-25−6,889→ 68,888 total
Sale
Viracta Therapeutics, Inc.$VIRX
Common Stock
2022-08-26$4.02/sh−3,655→ 82,376 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Restricted Stock Units
2022-08-25−6,889→ 75,777 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2022-08-25+6,889→ 86,031 total
Sale
Viracta Therapeutics, Inc.$VIRX
Common Stock
2022-05-26$1.90/sh−3,596→ 79,142 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2022-05-25+6,889→ 82,738 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Restricted Stock Units
2022-05-25−6,889→ 82,666 total
Award
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2022-03-17+195,000→ 195,000 total
Sale
Viracta Therapeutics, Inc.$VIRX
Common Stock
2022-02-28$2.78/sh−3,998→ 75,849 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2022-02-25+6,889→ 79,847 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Restricted Stock Units
2022-02-25−6,889→ 89,555 total
Sale
Viracta Therapeutics, Inc.$VIRX
Common Stock
2021-11-29$4.82/sh−4,325→ 72,958 total
Sale
Viracta Therapeutics, Inc.$VIRX
Common Stock
2021-11-26$4.80/sh−3,254→ 77,283 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Restricted Stock Units
2021-11-25−13,777→ 96,444 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2021-11-25+13,777→ 80,537 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2021-09-28$0.90/sh+10,000→ 66,760 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2021-09-28−10,000→ 88,817 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2021-05-28−12,000→ 98,817 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2021-05-28$0.90/sh+12,000→ 56,760 total
Award
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2021-03-26+78,912→ 78,912 total
Sale
Regulus Therapeutics Inc.
Common Stock
2019-07-01$1.31/sh−2,669→ 77,870 total
Sale
Regulus Therapeutics Inc.
Common Stock
2019-05-15$1.41/sh−10,000→ 80,539 total
Award
Regulus Therapeutics Inc.
Common Stock
2019-05-14+55,414→ 90,539 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2019-05-14+8,000→ 7,500 total

Companies

Recent Filings

Address

C/O LENZ THERAPEUTICS, INC. 201 LOMAS SANTA FE DRIVE, SUITE 300

SOLANA BEACH, CA, 92075

View on SEC.gov